Microsoft’s stock fell more than 6% on Thursday after guidance fell short of analysts’ estimates.
Jefferies says buy this pharmaceutical play, sees more than 100% upside from here
This pharmaceutical company’s recent drug developments could spell more gains ahead, according to Jefferies.